3^rd European Congress on Hematology July 11-12, 2022 Zurich, Switzerland

Anand P. Jillella, MD is a Professor in the Division of Hematology and Medical Oncology and the Medical Director of the Winship Cancer Network at Winship Cancer Institute of Emory University. In his role as Winship Medical Director, he leads the efforts of the Winship Cancer Network and expands Winship’s role in bringing clinical and population-based cancer research to communities throughout Georgia and surrounding states. Dr. Jillella received his Doctor of Medicine from the Government Medical College in Kurnool, India. He completed a rotating internship in Kurnool, followed by an internship at St. Agnes Hospital in Baltimore, MD, where he focused on pediatrics and internal medicine. He completed his residency at the Medical College of Georgia, and a fellowship in hematology/oncology at the Yale University School of Medicine. He did intensive training in bone marrow transplantation at the Johns Hopkins Oncology Center in Baltimore. He is board-certified in Medical Oncology

Bone marrow transplant, Research Interests, Acute Promyelocytic leukemia, Myeloma, Leukemia and Lymphoma

Anil K Tripathi is presently a Professor and the Head of the Department (HoD) at Clinical Hematology at the eminent King George Medical University (KGMU), Lucknow. He is an MD in Medicine, a fellow in Hematology NIH, Bethesda. His field of work is CML Multiple Myeloma ITP

Hematology and Multiple Myeloma

Prof Tiziano Barbui, graduated in Medicine and Surgery at the University of Padua. He founded the Department of Haematology at the Ospedali Riuniti of Bergamo in 1981 where he was Chief Executive Officer from 1981 to 2008. He is Professor of Hematology at University of Milan-Bicocca and Scientific Director of Foundation of Clinical Research - FROM, Ospedale Papa Giovanni XXIII, Bergamo, Italy. He has had the honor of being President of the Italian Society of Hematology. He has directed many international research groups in Hematology and currently coordinates the scientific activities of a group of the European-Leukemia-Net WP9 on Myeloproliferative Disorders. He was one of the four founders of a scientific consortium funded by the American NIH on chronic myeloproliferative diseases. He has served as a chairman on the Subcommittee on Lupus Anticoagulant of the International Society of Thrombosis and Haemostasis. During the plenary session of the European Society of Hematology (Stockholm in 2013) he received the Jean Bernard Prize, father of European haematology. The City of Bergamo awarded him the gold medal for his dedication to the sick and for his contributions to knowledge in Medicine. He is involved in other professional Societies, including the American Society of Haematology and the European Haematology Association. Main research interests are: Myeloproliferative Neoplasms (MPN), Thrombosis in Cancer, Congenital and Acquired Thrombophilia, and outcome research studies. He has published 650 scientific articles in peer reviewed journals. He is among the top 50 Italian scientists in the field of Medicine and Immunology

Thrombosis and Haemostasis, Haematolog, Myeloproliferative Neoplasms, Thrombosis in Cancer, Congenital and Acquired Thrombophilia

Prof Sasidharan Former Professor & Head, Department of Medicine &Hematology, Government Medical College, Kozhikode. Editorial Board Member Indian Journal of Hematology PhD research Guide for University of Calicut. Formerly: • Dean Faculty of Medicine, University of Calicut • Chairman PG Board of studies Kerala University of Health Sciences • President Association of Phsycians of India Kerala Chapter • Member Scientific Advisory committee- National Institute of immunohematology, Mumbai • PG Examiner for National Board, PGI Chandigarh, JIPMER, Bombay University, West Bengal University and other universities MBBS: 1976 – 1982-Best outgoing student M.D ,1983-86: from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh.

Hematology, Nutrition, life style disorders and Internal medicine

Shimon Slavin, M.D., is an Israeli professor of medicine. Slavin begin the use of immunotherapy mediated by allogeneic donor lymphocytes and innovative methods for stem cell transplantation for the cure of hematological malignancies and solid tumors, and using hematopoietic stem cells for induction of transplantation tolerance to bone marrow and donor allografts. More recently, he's been working on the use of multi-potent mesenchymal stem cells (MSCs) in regenerative medicine for the treatment of neurological, systemic and orthopedic disorders. He is currently serving as the medical and scientific director of Biotherapy International Center for Innovative Cancer Immunotherapy & Cellular Medicine in Tel Aviv, Israel and as the medical director at Superinfection, a biotechnology company in Budapest, Hungary. Slavin graduated from the School of Medicine at the Hebrew University of Jerusalem and got his degree in 1967. He served as the doctor of the Frogman Unit in the Israeli Navy until 1970. He was trained at the Department of Internal Medicine of the Hebrew University of Jerusalem between 1970 and 1975. In 1975-1978 Shimon Slavin trained in clinical immunology/rheumatology at the Division of Immunology, Stanford University School of Medicine and later on in 1978 trained in clinical bone marrow transplantation under the late Prof. E.D. Thomas at the Fred Hutchinson Cancer Research Center.

Hematology/oncology, Cancer immunotherapy, Regenerative Medicine, Stem cell transplantation, Stem cell treatment Leukemia, Lymphoma, Hodgkin lymphoma, Non-Hodgkin, lymphoma Myeloma Multiple sclerosis, Blood Cancer